271 related articles for article (PubMed ID: 12816828)
1. Acute coronary syndrome: ST segment elevation myocardial infarction.
Grech ED; Ramsdale DR
BMJ; 2003 Jun; 326(7403):1379-81. PubMed ID: 12816828
[No Abstract] [Full Text] [Related]
2. A comparison of therapeutic trends in myocardial infarction.
Milasinovic D; Teischinger L; Luerzer G; Mohl W
Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):15-9. PubMed ID: 19618592
[No Abstract] [Full Text] [Related]
3. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
[TBL] [Abstract][Full Text] [Related]
4. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
5. [Efficient revascularization of totally blocked left branch of coronary artery in cardiogenic shock complicating myocardial infarction of anterior and side heart wall].
Kawecki D; Kondys M; Kulej J; Michalewska-Włudarczyk A; Tomasik A; Switalska-Janiczek I
Kardiol Pol; 2006 Dec; 64(12):1449-51; discussion 1451-2. PubMed ID: 17206548
[No Abstract] [Full Text] [Related]
6. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
Borgia F; Goodman SG; Halvorsen S; Cantor WJ; Piscione F; Le May MR; Fernández-Avilés F; Sánchez PL; Dimopoulos K; Scheller B; Armstrong PW; Di Mario C
Eur Heart J; 2010 Sep; 31(17):2156-69. PubMed ID: 20601393
[TBL] [Abstract][Full Text] [Related]
7. Return to work after acute ST-segment elevation myocardial infarction in the modern era of reperfusion by direct percutaneous coronary intervention.
Isaaz K; Coudrot M; Sabry MH; Cerisier A; Lamaud M; Robin C; Richard L; Da Costa A; Khamis H; Abd-Alaziz A; Gerenton C
Arch Cardiovasc Dis; 2010 May; 103(5):310-6. PubMed ID: 20619241
[TBL] [Abstract][Full Text] [Related]
8. New trials and therapies for acute myocardial infarction.
Gumina RJ
Med Clin North Am; 2007 Jul; 91(4):729-49; xii. PubMed ID: 17640545
[TBL] [Abstract][Full Text] [Related]
9. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction.
van den Brand M; Ronner EF
Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877
[No Abstract] [Full Text] [Related]
10. Fibrinolysis and stenting in acute myocardial infarction: newlyweds destined for a 'ménage à trois'?
McFadden EP
Eur Heart J; 2001 Jul; 22(13):1067-9. PubMed ID: 11428845
[No Abstract] [Full Text] [Related]
11. [Myocardial revascularization in acute coronary syndrome without ST-segment elevation].
Hamon M
Rev Prat; 2003 Mar; 53(6):629-34. PubMed ID: 12749149
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary interventions for acute myocardial infarction.
Simsek C; Boersma E
EuroIntervention; 2011 Feb; 6(7):883-8. PubMed ID: 21252024
[No Abstract] [Full Text] [Related]
13. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
14. Reperfusion in acute myocardial infarction: current concepts.
Katritsis D; Karvouni E; Webb-Peploe MM
Prog Cardiovasc Dis; 2003; 45(6):481-92. PubMed ID: 12800129
[TBL] [Abstract][Full Text] [Related]
15. Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitors.
Lin GM; Chu KM; Han CL
Int J Cardiol; 2011 Jan; 146(2):280-2. PubMed ID: 21109318
[No Abstract] [Full Text] [Related]
16. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.
Bavry AA; Kumbhani DJ; Quiroz R; Ramchandani SR; Kenchaiah S; Antman EM
Am J Cardiol; 2004 Apr; 93(7):830-5. PubMed ID: 15050484
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
[TBL] [Abstract][Full Text] [Related]
18. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.
Laarman GJ; Suttorp MJ; Dirksen MT; van Heerebeek L; Kiemeneij F; Slagboom T; van der Wieken LR; Tijssen JG; Rensing BJ; Patterson M
N Engl J Med; 2006 Sep; 355(11):1105-13. PubMed ID: 16971717
[TBL] [Abstract][Full Text] [Related]
20. [The early management of ST-elevation acute myocardial infarction in the Lombardy Region (GestIMA)].
Oltrona L; Mafrici A; Marzegalli M; Fiorentini C; Pirola R; Vincenti A;
Ital Heart J Suppl; 2005 Aug; 6(8):489-97. PubMed ID: 16161503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
